None
Quote | Organogenesis Holdings Inc. (NASDAQ:ORGO)
Last: | $2.90 |
---|---|
Change Percent: | 1.4% |
Open: | $2.82 |
Close: | $2.90 |
High: | $2.91 |
Low: | $2.81 |
Volume: | 421,209 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Organogenesis Holdings Inc. (NASDAQ:ORGO)
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today a...
2024-03-01 18:29:39 ET This earnings season, quite a few healthcare companies notched solid beats on revenue, earnings, or both. Unfortunately for its shareholders, Organogenesis Holdings (NASDAQ: ORGO) was not one of them. The wound care specialist published its fourth-quarter ...
Message Board Posts | Organogenesis Holdings Inc. (NASDAQ:ORGO)
Subject | By | Source | When |
---|---|---|---|
The gaining last up | Attila1905 | investorshub | 05/10/2023 6:06:10 AM |
$ORGO Good news recently, we should start to see this one move | Roadtojourney | investorshub | 05/10/2023 2:20:01 AM |
$ORGO MomentumIts gaining last trade up | Attila1905 | investorshub | 05/09/2023 6:14:36 PM |
$ORGO Price now last trade up | lvhd | investorshub | 05/09/2023 3:04:22 AM |
what do you make of this data? | Apophis | investorshub | 05/08/2023 4:46:25 AM |
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on ...
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today a...
2024-03-01 18:29:39 ET This earnings season, quite a few healthcare companies notched solid beats on revenue, earnings, or both. Unfortunately for its shareholders, Organogenesis Holdings (NASDAQ: ORGO) was not one of them. The wound care specialist published its fourth-quarter ...